The 31st Vietnam International Medical and Pharmaceutical Exhibition (Vietnam Medipharm Expo 2024) is scheduled to take place in Hanoi from May 9 to 12, an official of the Ministry of Health (MoH) told a press conference on April 19.
Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and cheapest prices during a meeting in Hanoi on February 19 to discuss the law on amendments and supplementations to some articles of the Law on Pharmacy.
Vietnam and Algeria have potential for cooperation in trade, industry and energy, according to Minister of Industry and Trade Nguyen Hong Dien.
The Vietnam international exhibition on products, equipment, supplies for medical, pharmaceutical, hospital and rehabilitation – Pharmedi Vietnam 2023 - kicked off in Ho Chi Minh City on September 13.
VOV.VN - Prime Minister Pham Minh Chinh has called on US healthcare giant Abbott to expand its investment and upgrade the quality of its pharmaceutical manufacturing plants in Vietnam as a way of promoting the domestic pharmaceutical industry.
A delegation of the Vietnamese Ministry of Health led by Deputy Minister Do Xuan Tuyen has attended the BIO International Convention in the US’ Boston city from June 5-8.
The 28th Vietnam Medi-pharm Expo will take place from December 1-3 in Hanoi, giving a chance for businesses to seek partners and popularise their products and technologies.
The ultimate goal of the development programme for domestic pharmaceutical industry is to ensure the sufficient supply of medicines at reasonable costs for the people, said Deputy Prime Minister Vu Duc Dam at a meeting held in Hanoi on September 21.
VOV.VN - Prime Minister Pham Minh Chinh has assigned the President Ho Chi Minh Mausoleum Management Board to closely coordinate with Russian scientists and medical experts in preserving the body of President HCM with the highest responsibility.
The first half of this year saw flows of foreign investment from the Republic of Korea (RoK) and Singapore, among others, in domestic pharma startups.